tirzepatide and retinopathy A Sankey diagram displaying change in status in the Early worsening of diabetic retinopathy
Description
In conclusion, the researchers found that semaglutide is a promising weight loss treatment option for individuals with overweight or obesity
2022 [cited 2022 Jun 15];12:454
Irritable bowel syndrome (IBS): IBS is a common condition where someones small intestine and colon are more sensitive to normal GI functions
However, there are also patients who have taken Ozempic or one of the other drugs who have reported experiencing severe stomach issues (such as nausea, vomiting, or diarrhea lasting more than four weeks) and gastroparesis
